Henry Schein (Nasdaq:HSIC) announced today that it completed the acquisition of a majority ownership stake in Biotech Dental. Salon-de-Provence, France-based Biotech Dental provides dental implants, clear aligners and digital dental software. Melville, New York-based Henry Schein announced its plans to acquire a majority stake on Dec. 16, 2022. Biotech Dental’s offerings include Nemotec, an integrated […]